In this webinar hosted by Dr. Madhuri Koti, we explore the combined impact of biological sex differences and aging on bladder cancer, including how both factors influence risk, diagnosis, treatment, and outcomes. Gain a deeper understanding of how these elements shape bladder cancer care and ongoing research into gender-specific and age-related responses to treatment.
Understanding the Role of Aging and Sex in Bladder Cancer
As Dr. Koti explains, aging and sex are two critical but often overlooked factors in cancer research. Older adults face higher incidence rates and unique challenges in treatment tolerance, while biological sex influences not only who develops bladder cancer, but also how they respond to therapies such as BCG and chemotherapy.
Biological and Social Factors That Influence Risk
The presentation explores a variety of biological and social risk factors, like how genetics, hormones, and immune system differences contribute to bladder cancer outcomes. It also highlights how social and environmental factors, such as occupational exposure, access to healthcare, and lifestyle, affect cancer detection and survival differently for men and women.
Why This Research Matters for the Future of Cancer Care
Dr. Koti’s discussion emphasizes the importance of personalized treatment strategies that account for aging and sex-based biological differences. These insights could help guide future therapies that are more effective and equitable for all patients living with bladder cancer.
Learn More About Bladder Cancer and Access Support
Bladder Cancer Canada is here to provide trusted education, advocacy, and community support for patients and caregivers. Discover how to get involved with Bladder Cancer Canada and learn more about care options and ongoing research. If you have questions or need guidance, please reach out. Our team is here to help.
